Mohammad Eslami, MD
Vascular Surgery · Charleston, WVNPI 1780665786
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Medtronic at 44.9% of the total. Reporting peaked in 2024 at $2,416 and has fallen 60.6% since, to $951 in 2025.
Across 42 payments — averaging $135.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$1K
- Johnson & Johnson$188
- Bolton Medical Inc$168
- Penumbra, Inc.$148
- plus $418 from 5 others
What the payments were for
- Travel & lodging$2,88751%
- Food & beverage$2,81949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $2,560 |
| Silk Road Medical, Inc. | 7 | $1,136 |
| W. L. Gore & Associates, Inc. | 11 | $1,087 |
| Johnson & Johnson(2 entities) | 2 | $188 |
| Bolton Medical Inc | 2 | $168 |
| Penumbra, Inc. | 1 | $148 |
| Getinge USA Sales, LLC | 1 | $146 |
| Thrombolex, Inc. | 1 | $127 |
| Cook Medical LLC | 1 | $69 |
| Smith+Nephew | 1 | $55 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Valiant Captivia$2,000
- ENROUTE Transcarotid Neuroprotection System$931
- ENROUTE Transcarotid Stent System$931
- ENHANCE Transcarotid Peripheral Access Kit$931
- ENROUTE 0.014 Guidewire$931
- ENDURANT IIS$317
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$236
- GORE TAG Thoracic Branch Endoprosthesis$215
- GORE VIABAHN VBX Balloon Expandable Endo$174
- EXCLUDER AAA Endoprosthesis$158
- Penumbra System$148
- FLIXENE$146
- Bashir Endovascular Catheter$127
- XARELTO$125
- TREO ABDOMINAL STENT-GRAFT SYSTEM$117
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$110
How this compares
$5,705 in reported general payments places this provider in the 60th percentile of 32 vascular surgery providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 19 | $166 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Charleston
- Shadi Abu HalimahCharleston$38K
- John CampbellCharleston$12K
- Andrew LeeCharleston$11K
- Matthew BeasleyCharleston$9K
- Zachary AburahmaCharleston$8K
- Ali AburahmaCharleston$6K
- Meghan JordanCharleston$4K
- Stephen HassCharleston$3K
- Christina VeithCharleston$2K
- Edward TileyCharleston$147
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.